JPRN-UMIN000016730招募中1 期
A phase I/II study of carboplatin in combination with nab-paclitaxel and thoracic radiation in elderly patients with previously untreated non-small cell lung cancer - A phase I/II study of carboplatin in combination with nab-paclitaxel and thoracic radiation in elderly patients with previously untreated non-small cell lung cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 43
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 75years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Radiographically (chest CT image) confirmed interstitial pneumonitis or pulmonary fibrosis 2)V20 exceed 35% 3)Patients with opposite hilar lymph nodes metastases, or massive pleural or pericardial effusion 4)Patients with active double cancer 5)Patients with serious disease condition (severe infections,diarrhea,ileus,poorly controlled diabetes, unstable angina,cardiac infarction within 6 months before enrollment,severe heart failure, etc.) 6)Severe emphysema, chronic bronchitis, asthma 7)Postoperative relapse 8)History of drug-induced pneumonia or severe drug allergies 9)History of hypersensitivity to albumin preparations 10)Grade 2 or higher peripheral neuropathy 11)Patients with severe mental illness 12)HBs antigen positive, or HBV-DNA positive ( HBs antigen negative but HBs antibody or HBc antibody positive) 13)Unsuitable patients judged by the attending physician
研究者
相似试验
未知
2 期
Phase II study in combination with Carboplatin and TS-1 for Cancer of unknown primaryCancer of unknown primaryJPRN-UMIN000001236ational Cancer Center Hospital, Tokyo35
进行中（未招募）
2 期
A Randomised Phase II Study Of nab-paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine CarcinomasACTRN12616000958482Australasian Gastro-Intestinal Trials Group (AGITG)60
已完成
2 期
A Phase II first-line study of Carboplatin plus Pemetrexed in elderly patients with advanced non-small, non-squamous cell lung canceron-Small, Non-Squamous Cell Lung CancerJPRN-UMIN000004635Kochi University, School of Medicine, Department of Hematology and Resporatory Medicine35
招募中
1 期
Phase I/II study of Carboplatin plus Nab-Paclitaxel in patients with advanced non-small-cell lung cancer and a performance status of 2on-small-cell lung cancerJPRN-UMIN000014544Shizuoka cancer center33
进行中（未招募）
不适用
A randomised Phase II study of carboplatin with or without the addition of the ETAR inhibitor ZD4054 as treatment for patients with metastatic breast cancer. - PLANETMetastatic Breast CancerEUCTR2010-018837-23-GBCardiff University